(Q39796854)

English

Prevalence and clinical significance of prostate cancer among 12,682 men with normal digital rectal examination, low PSA levels (< or =4 ng/ml) and percent free PSA cutoff values of 15 and 20%.

scientific article published on January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Prevalence and clinical significance of prostate cancer among 12,682 men with normal digital rectal examination, low PSA levels (< or =4 ng/ml) and percent free PSA cutoff values of 15 and 20%. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Pietro Pepe

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Paolo Panella

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Francesco Savoca

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Antonio Cacciola

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Letterio D'Arrigo

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Giuseppe Dibenedetto

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Michele Pennisi

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Francesco Aragona

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Urologia Internationalis

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

78

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

308-312

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Extensive biopsy protocol improves the detection rate of prostate cancer

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Identification of clinically significant prostate cancer by prostate-specific antigen screening

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of < 4.0 ng/mL.

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Gleason grading and prognostic factors in carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies

1 reference

https://api.crossref.org/works/10.1159%2F000100833

21 January 2018

Identifiers

10.1159/000100833

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

release_57oqxxzq3verveavz77dvezibe

1 reference

https://api.fatcat.wiki/v0/release/57oqxxzq3verveavz77dvezibe

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39796854&oldid=2090511915"